Related references
Note: Only part of the references are listed.Controversies in Mucosal Healing in Ulcerative Colitis
Sunanda Kane et al.
INFLAMMATORY BOWEL DISEASES (2009)
Can calprotectin predict relapse risk in inflammatory bowel disease?
Renata D'Inca et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
The role of endoscopic assessment in ulcerative colitis in the era of infliximab
M. Daperno et al.
DIGESTIVE AND LIVER DISEASE (2008)
Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease
R. Berni Canani et al.
DIGESTIVE AND LIVER DISEASE (2008)
Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies
Alain M. Schoepfer et al.
INFLAMMATORY BOWEL DISEASES (2008)
Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease
Dorota Walkiewicz et al.
INFLAMMATORY BOWEL DISEASES (2008)
Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease
Michael Wagner et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Diagnostics of inflammatory bowel disease
Susanna Nikolaus et al.
GASTROENTEROLOGY (2007)
Accuracy of four fecal assays in the diagnosis of colitis
Alain M. Schoepfer et al.
DISEASES OF THE COLON & RECTUM (2007)
Mucosal healing in inflammatory bowel disease: Results from a Norwegian population-based cohort
Kathrine Frey Froslie et al.
GASTROENTEROLOGY (2007)
Cytomegalovirus colitis complicating inflammatory bowel disease
Ahmed Kandiel et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Oratory markers in IBD: Magic, or unneccessary toys?
S Vermeire et al.
GUT (2006)
Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis
J Langhorst et al.
INFLAMMATORY BOWEL DISEASES (2005)
5-aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study
TP van Staa et al.
GUT (2005)
Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels
CS Carlson et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: A systematic review and metaanalysis of observational studies
FS Velayos et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease
F Costa et al.
GUT (2005)
Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease
AG Roseth et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2004)
Faecal calprotectin: a marker of inflammation throughout the intestinal tract
CB Summerton et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2002)
Review article: is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease
IDR Arnott et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitis
RK Linskens et al.
DIGESTIVE DISEASES AND SCIENCES (2001)
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis
A Bitton et al.
GASTROENTEROLOGY (2001)
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease
JA Tibble et al.
GASTROENTEROLOGY (2000)
Share Paper
